Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.
Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9?Million US Veterans.
Recent advances in otitis media. 3. Animal models; anatomy and pathology; pathogenesis; cell biology and genetics.
Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol.
Cardiovascular and Renal Outcomes Trials-Is There a Difference?
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
My Person List (
0
)
Return to Top
Cardiovascular and Renal Outcomes Trials-Is There a Difference?
Cardiovascular and Renal Outcomes Trials-Is There a Difference? Am J Cardiol. 2015 Sep 15; 116(6):982-8.
View in:
PubMed
subject areas
Cardiovascular Agents
Cardiovascular Diseases
Humans
Kidney Failure, Chronic
Randomized Controlled Trials as Topic
Renal Dialysis
Research Design
authors with profiles
Kamyar Kalantar-Zadeh M.D., MD, PhD